We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.68%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$413M
AUM Growth
-$3.2M
(-0.77%)
Cap. Flow
-$7.27M
Cap. Flow
% of AUM
-1.76%
Top 10 Holdings %
Top 10 Hldgs %
30.14%
Holding
1,129
New
83
Increased
245
Reduced
309
Closed
247
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$21.4M |
| 2 |
Stellantis
STLA
|
+$18M |
| 3 |
CNH
CNH Industrial
CNH
|
+$11.6M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.3M |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$6.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$23.5M |
| 2 |
Linde
LIN
|
+$8.45M |
| 3 |
Visa
V
|
+$5.42M |
| 4 |
Alcon
ALC
|
+$3.14M |
| 5 |
T-Mobile US
TMUS
|
+$3.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.6% |
| 2 | Technology | 15.31% |
| 3 | Miscellaneous | 15.03% |
| 4 | Industrials | 9.82% |
| 5 | Financials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
TG Therapeutics
TGTX
$8.12B
| – | – |
-5,368
| Closed | -$179K |
|
977
Tenet Healthcare
THC
$21B
| – | – |
-1,889
| Closed | -$126K |
|
978
Thor Industries
THO
$3.71B
| – | – |
-2,642
| Closed | -$324K |
|
979
TJX Companies
TJX
$137B
| – | – |
-28
| Closed | -$1.85K |
|
980
Tilray
TLRY
$560M
| – | – |
-307
| Closed | -$34.7K |
|
981
Toyota
TM
$231B
| – | – |
-58
| Closed | -$10.3K |
|
982
Tencent Music
TME
$12.9B
| – | – |
-5,100
| Closed | -$37K |
|
983
Thermo Fisher Scientific
TMO
$237B
| – | – |
-4,194
| Closed | -$2.4M |
|
|
984
T-Mobile US
TMUS
$194B
| – | – |
-23,815
| Closed | -$3.04M |
|
985
Travel + Leisure Co
TNL
$4.01B
| – | – |
-4
| Closed | -$218 |
|
986
Toll Brothers
TOL
$12.4B
| – | – |
-1,545
| Closed | -$85.4K |
|
|
TPIC
987
DELISTED
TPI Composites
TPIC
| – | – |
-7,609
| Closed | -$257K |
|
988
Tapestry
TPR
$23.4B
| – | – |
-8
| Closed | -$296 |
|
989
TripAdvisor
TRIP
$1.06B
| – | – |
-1
| Closed | -$34 |
|
990
Trimble
TRMB
$13.7B
| – | – |
-6,822
| Closed | -$561K |
|
991
Trinity Industries
TRN
$2.24B
| – | – |
-8,165
| Closed | -$222K |
|
992
Terreno Realty
TRNO
$7.11B
| – | – |
-2,344
| Closed | -$148K |
|
993
TC Energy
TRP
$63.6B
| – | – |
-8,568
| Closed | -$410K |
|
994
TransUnion
TRU
$14.8B
| – | – |
-19
| Closed | -$2.13K |
|
995
Trupanion
TRUP
$1.15B
| – | – |
-1,760
| Closed | -$137K |
|
996
Tenaris
TS
$28.6B
| – | – |
-12,656
| Closed | -$267K |
|
997
Tractor Supply
TSCO
$17.2B
| – | – |
-18,120
| Closed | -$734K |
|
998
TSMC
TSM
$2.15T
| – | – |
-9,073
| Closed | -$1.01M |
|
999
Tyson Foods
TSN
$18.5B
| – | – |
-6,227
| Closed | -$492K |
|
1000
Tetra Tech
TTEK
$9.4B
| – | – |
-18,735
| Closed | -$560K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2021 Portfolio in Review
As of Q4 2021, Exane Derivatives held 1,129 positions worth $413M, down 0.77% from $417M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Exane Derivatives's Q4 2021 filing shows 83 new, 245 increased, 309 reduced and 247 closed positions. Its largest new stake was EngageSmart, Inc.: 45,605 shares worth $1.1M. The largest sale was UBS Group, an estimated $23.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 11% a quarter earlier, followed by Technology and Miscellaneous.
- Exane Derivatives's largest Q4 2021 buy was EngageSmart, Inc.: 45,605 shares worth $1.1M.
- Exane Derivatives added most to Ferrari in Q4 2021, an estimated $21.4M increase.
- Exane Derivatives's biggest Q4 2021 reduction was UBS Group, cutting an estimated $23.5M.
- Exane Derivatives fully exited Visa in Q4 2021, selling an estimated $5.42M.
- Exane Derivatives's ten largest holdings make up 30% of its $413M portfolio in Q4 2021.
- Exane Derivatives opened 83 new positions and closed 247 in Q4 2021.
- Exane Derivatives's portfolio value fell 0.77% quarter-over-quarter to $413M.
Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.